← FDA Drug Approvals (Drugs@FDA)

CINVANTI

NDA · New Drug Application · Sponsor: HERON THERAPS INC · Approved 2017-11-09

Drug application

FDA Application #

NDA209296

Application type

New Drug Application

Brand name

CINVANTI

Generic name

APREPITANT

Active ingredients

APREPITANT

Dosage form

EMULSION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

HERON THERAPS INC

Manufacturer

Heron Therapeutics, Inc.

First approval

2017-11-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown